NR1H4 and bone neoplasm: However, activation of FXR by GW4064 was reported to increase miR-23b-3p, which lead to the suppression of cyclin G1 and cell proliferation and the inhibition of miR-23b-3p reverses this effect in MG-63 bone cancer cells.